Heidelberg Pharma AG (HPHA.DE) XETRA

Currency In EUR

AD

Valuation

Market Cap134.41M
Enterprise Value120.59M
P/E Ratio-3.03
PEG Ratio0.04
Price/Sales Ratio37.94
Price/Book Ratio-8.18
Enterprise/Revenue35.08
Enterprise/EBITDA-2.91

Fiscal Year

Fiscal YearNovember 30, 2025
Most Recent QuarterFebruary 28, 2026

Profitability

Profit Margin-12.62
Operating Margin-12.88
AD

Management Effectiveness

Return On Assets-1.32
Return On Equity-54.61

Income Statement

Revenue1.46M
Revenue/Share0.07
Gross Profit-1.63M
EBITDA-44.63M
Net Income-42.28M
Diluted EPS-0.91

Balance Sheet

Total Cash9.26M
Total Cash/Share0.19
Total Debt77,404
Total Debt/Equity-0.01
Current Ratio2.4
Book Value Per Share-0.32

Price History

52-Week Change-33.25
52-Week High4.97
52-Week Low2.33
Moving Average 50 Days2.73
Moving Average 200 Days2.91

Statistics

Average Volume2,812
Shares Outstanding46.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateJuly 18, 2014
AD